According to Lejawa et al., MUO subjects had higher levels of visfatin than did people with MHO and MHNW, implying that this adipokine may have an effect on the development of obesity-related metabolic disorders (Table 2) [79]. The gene discussed is NAMPT; the disease is metabolic disease.